Fetal RHD detection from circulating cell‐free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA-Reference-Cited by-同舟云学术

Fetal RHD detection from circulating cell‐free fetal DNA in maternal plasma: validation of a diagnostic kit using automatic extraction and frozen DNA

Published:2019-06-17 Issue:6 Volume:29 Page:408-414
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Med

Author:

Londero D.¹^ORCID,Stampalija T.²,Bolzicco D.¹,Castro Silva E.²,Candolini M.¹,Cortivo C.²,Dreossi C.¹,Fantasia I.²,Pecile V.²,De Angelis V.¹

Affiliation:

1. Department of Transfusion MedicineASUI‐Udine Udine Italy

2. Unit of Fetal Medicine and Prenatal DiagnosisInstitute for Maternal and Child Health, IRCCS Burlo Garofolo Trieste Italy

Funder

GENIC

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tme.12605

Reference25 articles.

1. Specificity and sensitivity of RHD genotyping methods by PCR‐based DNA amplification

2. Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxis

3. Noninvasive fetal RhD genotyping

4. Routine noninvasive prenatal screening for fetal RHD in plasma of RhD‐negative pregnant women–2 years of screening experience from Denmark;Clausen F.B.;Prenatal Diagnosis,2014

5. Anti‐D administration in pregnancy for preventing rhesus alloimmunisation;Crowther C.A.;Cochrane Database of Systematic Reviews,2000

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Blood Transfusion Service Delivery across the West African Sub-Region;Thalassemia Syndromes - New Insights and Transfusion Modalities;2023-11-22

2. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy;BLOOD TRANSFUS-ITALY;2023

3. Recommendation for validation and quality assurance of non‐invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations;Vox Sanguinis;2021-06-21

4. Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status;Archives of Gynecology and Obstetrics;2021-04-09

5. Overview of non-invasive fetal blood group genotyping;Annals of Blood;2021-01